Signifier Medical Technologies Announces Participation In Morgan Stanley 2019 Global Medtech Conference

snoozeal product controller and main product

London, United Kingdom

July 15, 2019 – Signifier Medical Technologies, a medical technology company developing innovative sleep-disordered breathing products for use in the homecare setting, today announced that the Company’s management will be participating in the 2019 Global MedTech conference in New York.

Signifier Medical’s Co-founder and CEO, Akhil Tripathi is scheduled to present on Monday, September 9, 2019 at 9:55 a.m. ET at the Morgan Stanley 2019 Global MedTech Conference.

About Signifier Medical Technologies

Signifier Medical Technologies, previously known as eXciteOSA®, is a medical technology company focused on the development and commercialization of innovative and non-invasive solutions for patients with snoring and sleep-disordered breathing conditions.

Signifier’s proprietary therapy is the first and only day time genioglossal muscle-neurostimulation technology, with proven clinical data from prestigious and well-recognised universities and academic institutions, that provides a safe and effective treatment for its patients.

For media enquiries:
+44 (0) 207 096 0586